Opioid maker Teva agrees to tentative $4.25 billion deal - The Washington Post
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
TEVA.N - | Stock Price & Latest News | Reuters
Should You Sell Teva Pharmaceutical Industries Ltd (TEVA) in Drug Manufacturers - Specialty & Generic Industry?
Pharma giant Teva looks to steady ship with new CEO in coming weeks - The Times of Israel
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
The best Teva sandals to wear this summer
Teva shares plunge as competitors get nod for copycat flagship drug - The Times of Israel
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva Pharmaceuticals Europe | Amsterdam
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily
New York court dismisses most of Teva claims against Mexican drugmakers - The Times of Israel
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? | InvestorPlace
Articles about Teva Pharmaceuticals
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva, Glenmark enter deferred prosecution deal DOJ over price fixing
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Articles about Teva Pharmaceuticals, Inc.
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva settlement prevents Lupin from launching its Austedo generic until 2033 | Fierce Pharma
